PENTAMIDINE TILLOMED 300 mg, powder for solution for injection/for infusion or for inhalation by nebulizer bottle, 20 ml
Active ingredients: Pentamidine isethionate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusion or for inhalation by nebulizerbottle, 20 mlinhalée;intramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PENTAMIDINE TILLOMED 300 mg, poudre pour solution injectable/pour perfusion ou pour inhalation par nébuliseur
- Pharmaceutical form
- poudre pour solution injectable pour perfusion ou pour inhalation par nébuliseur
- Route of administration
- inhalée;intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- TILLOMED PHARMA (ALLEMAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61094142CIP73025534CIP133400930255346Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DIISÉTHIONATE DE PENTAMIDINEpoudre | 300 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.